Search Results - "Barna, B.P."

An open-label trial of rituximab therapy in pulmonary alveolar proteinosis by KAVURU, M. S, MALUR, A, MARSHALL, I, BARNA, B. P, MEZIANE, M, HUIZAR, I, DALRYMPLE, H, KARNEKAR, R, THOMASSEN, M. J

“…Rituximab, a monoclonal antibody directed against the B-lymphocyte antigen CD20, has shown promise in several autoimmune disorders. Pulmonary alveolar…”
Get full text

Activin A Deficiency: Association with Autoimmune Lung Disease by Thomassen, M.J., Bonfield, T.L., Barna, B.P., John, N., Kavuru, M.S.

“…RATIONALE: Because pulmonary alveolar proteinosis (PAP) is an autoimmune lung disorder characterized by neutralizing autoantibodies to granulocyte-macrophage…”
Get full text

PPAR-γ activity is deficient in alveolar macrophages of allergic asthmatics by Rambasek, T.E., Follettie, M.T., Wang, I.W., Wei, S., Cai, J., Bonfield, T.L., Malur, A., Barna, B.P., Isabella, T., Goldman, S.L., Kavuru, M.S., Kobayashi, M., Thomassen, M.

“…Recent studies have suggested that peroxisome proliferator-activated receptor-γ (PPAR-γ), a ligand-activated nuclear transcription factor, may be a negative…”
Get full text

Astrocyte Cultures Derived from Human Brain Tissue Express Angiotensinogen mRNA by Milsted, Amy, Barna, Barbara P., Ransohoff, Richard M., Brosnihan, K. Bridget, Ferrario, Carlos M.

“…We have identified human cultured cell lines that are useful for studying angiotensinogen gene expression and its regulation in the central nervous system. A…”
Get full text

Epidermal Growth Factor Regulates Astrocyte Expression of the Interleukin-4 Receptor via a MAPK-Independent Pathway by Barna, B.P., Mattera, R., Jacobs, B.S., Drazba, J., Estes, M.E., Prayson, R.A., Barnett, G.H.

“…Human astrocytes express the interleukin (IL)-4 receptor alpha chain (IL-4Rα) in vitro and in vivo but mechanisms governing astrocyte IL-4Rα expression have…”
Get full text

Immune mechanisms in beryllium lung disease by Deodhar, S D, Barna, B P

“…The role of the immune system in the pathogenesis of beryllium lung disease has been suspected for years. The observation of cutaneous hypersensitivity to…”
Get more information

Immunologic changes in renal cell carcinoma patients receiving gamma interferon by Barna, B P, Thomassen, M J, Sergi, J, Murthy, S, Bukowski, R M

“…Immunologic changes were monitored in 5 patients with metastatic renal cell carcinoma participating in a phase II trial of recombinant interferon gamma (rIFN…”
Get more information

A lymphocytotoxic factor(s) in plasma of patients with minimal change nephrotic syndrome: partial characterization by Barna, B P, Makker, S, Kallen, R, Valenzuela, R, Deodhar, S D, Yeip, M, Leto, D, Verbic, M A, Rajaraman, S, Govindarajan, S

“…The incidence, relationship to clinical disease, and physical characteristics of a plasma cytotoxic factor(s) were studied in steroid-responsive minimal change…”
Get more information